SCHEMBL4607447

SCHEMBL4607447

O=C(O)C(=O)/C=C/c1ccc(Cl)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.46
MAOB P27338 4/20 0.46
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
DAO P14920 1/20 0.42
KMT2A Q03164 3/20 0.41
MAPK1 P28482 1/20 0.41
BCHE P06276 1/20 0.39
F2 P00734 1/20 0.38
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 3/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
RAB9A P51151 2/20 0.36
MDM2 Q00987 1/20 0.36
GSK3B P49841 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607453 1.00 MAOA (0.46) MAOAMAOBPTGS1PTGS2DAO
SCHEMBL77016 0.85 MAPK1 (0.56) MAOAMAOBPTGS1PTGS2DAO
SCHEMBL77017 0.85 MAPK1 (0.56) MAOAMAOBPTGS1PTGS2DAO
SCHEMBL9520373 0.81 MAOA (0.51) MAOAMAOBPTGS1PTGS2DAO
SCHEMBL9520363 0.81 MAOA (0.51) MAOAMAOBPTGS1PTGS2DAO
SCHEMBL17157652 0.78 DAO (0.42) DAOKMT2AMAPK1ALDH1A1KDM4E
SCHEMBL17157651 0.78 DAO (0.42) DAOKMT2AMAPK1ALDH1A1KDM4E
SCHEMBL3516804 0.75 MAOA (0.47) MAOAMAOBPTGS1PTGS2DAO
SCHEMBL4387123 0.75 MAOA (0.53) MAOAMAOBPTGS1PTGS2KMT2A
SCHEMBL4387119 0.75 MAOA (0.53) MAOAMAOBPTGS1PTGS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
WO-2007009690-A1 HETEROCYCLYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A (ES) 2007-01-25 WO disclosed
WO-2007009690-A1 HETEROCYCLYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A (ES) 2007-01-25 WO disclosed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed